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BACKGROUND The association between anemia at admission and
adverse outcome in patients with acute coronary syndromes (ACS) has
been recently emphasized. A more granular analysis between baseline
hemoglobin and adverse events has not been reported.
METHODS Anemia was deﬁned as serum hemoglobin <12 g/dl in
women and <13 g/dl in men in two large ACS trials – ACUITY and
HORIZONS-AMI. We plotted gender–speciﬁc hazard functions for all-
cause mortality at 1 year and major bleeding at 30 days according to
baseline hemoglobin, and analyzed time to events according to ter-
tiles of hemoglobin.
RESULTS Among 16,421 patients, 2,558 (15.6%) had anemia at base-
line. Patients with anemia were older, more often women, and had
higher rates of CAD risk factors. They were also signiﬁcantly more
likely not to undergo revascularization. The hemoglobin level on
admission was 11.71.0 g/dl in anemic and 14.61.2 g/dl in non-
anemic patients (P<0.001). The incidence of ischemic events in the
two groups is shown in Table 1. Death and MI were signiﬁcantly more
common in anemic patients at 30 days and at 1 year, while rates of ST,
TLR and TVR were similar. Non-CABG major bleeding was 2x as
common in the anemic patients (8.4% vs. 3.6%, P<0.001), and
transfusions were administered 5x more often (7.5% vs. 1.5%,
P<0.001). Patients in the highest tertile of hemoglobin (>14.8 g/dl)
has the lowest 1-year mortality, compared with the middle tertile
(13.5-14.8 g/dl) and lowest tertile (<13.5 g/dl): 3.0% vs. 3.4% vs.
5.8%, P<0.0001, respectively. There was no signiﬁcant difference
between the middle and highest tertile of baseline hemoglobin
(P¼0.08). Gender-speciﬁc spline transformations of the hazard for
death at 1 year as a function of hemoglobin level on admission
showed that the lowest mortality was observed at a baseline
hemoglobin level of 14.6 g/dl for men and 13.2 g/dl for women.
Below and above these levels mortality increased (U-shaped curve).
The lowest rate of major bleeding events occurred at similar
hemoglobin levels as for mortality.
CONCLUSIONS Baseline hemoglobin carries important prognostic
information and appears to have a non-linear association with both
death and major bleeding events. The risk for mortality and major
bleeding increases with hemoglobin levels below and above 14.6 g/dl
for men and 13.2 g/dl for women.Anemia No Anemia p value30 DAY EVENTSDeath 3.1% (78) 1.5% (203) <0.0001Reinfarction 5.5% (139) 4.3% (593) 0.008Death or reinfarction 7.9% (201) 5.5% (757) <0.0001Deﬁnite stent
thrombosis0.4% (11) 0.8% (103) 0.08Target vessel
revascularization1.2% (30) 1.6% (221) 0.111-YEAR EVENTSDeath 7.4% (184) 3.5% (442) <0.0001Reinfarction 8.5% (203) 6.4% (857) 0.0005Death or reinfarction 14.7% (359) 9.2% (1212) <0.0001Deﬁnite stent
thrombosis0.8% (19) 1.2% (156) 0.09Target vessel
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BACKGROUND The temporal changes in the clinicopathological
characteristics of cardiac rupture (CR) are ill-deﬁned.
METHODS 187 consecutive decedents with acute myocardial infarc-
tion (AMI) and fatal CR of the left ventricular free wall and/or septum
whose autopsies were performed at Mayo Clinic between 1986 and
2012 were included and their clinical and autopsy characteristics were
studied. Overall autopsies were divided into three groups: group 1
(N¼100) (1986-1995); (N¼49) group 2, (1996-2004); and group 3 (N¼38)
(2005-2012).
RESULTS Median age of decedents at CR did not change from be-
tween the 3 groups (76, 76, 72; p¼0.35), however, the prevalence of
hypertension and prior MI decreased with time. The most common
clinical and anatomical site of CR in groups 2 and 3 were at the edge of
an inferolateral infarct (Fig 1). Median infarct age remained the same
(Table 1). Plaque rupture was seen less commonly, however, severe




(N[38) PAge, median 76 76 72 0.35Men 49% 55% 53% 0.77Hypertension 72% 65% 50% 0.12Diabetes 21% 31% 21% 0.53Smoking history 31% 56 55% 0.026Prior MI 22% 15% 0 0.07Presentation with chest pain 75% 77% 40% 0.0073 vessels with Grade 4 atherosclerosis 29% 43% 51% 0.035Plaque rupture not seen 19% 48% 74% <0.001Acute thrombus 80% 70% 66% 0.21Infarct site0.14
- Anterior 45% 33% 26%- Inferior 35% 41% 37%- Lateral 19% 27% 37%Median infarct age, days 4 3.5 4 0.08Rupture Site with Infarct0.52Central 32% 43% 42%Peripheral 65% 57% 58%
